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STATEMENT OF JURISDICTION 
The District Court of Utah County entered Summary 
Judgment In Favor Of Searle Pharmaceuticals, Inc.; thereafter, 
the Court entered a Certification For Appeal establishing the 
Summary Judgment as a "final order". From the Summary Judgment 
and Certification, the plaintiff appeals to this Court in accor-
dance with the provisions of Rule 54(a) and (b), Utah Rules of 
Civil Procedure; and Rule 3(a), Rules of the Utah Supreme Court. 
STATEMENT OF THE ISSUE 
Whether the District Court correctly granted Summary 
Judgment in Favor Of Searle Pharmaceuticals, Inc. in view of the 
plaintiff's failure to produce expert testimony to establish 
that the Cu-7, intrauterine copper contraceptive, caused injury 
to the plaintiff. 
STATEMENT OF THE CASE 
A. NATURE OF THE CASE 
This is a medical malpractice action against the de-
fendant, Doran V. Porter, M.D. ("Dr. Porter") arising out of his 
alleged negligence in connection with the insertion of a Cu-7 
intrauterine copper contraceptive into the uterus of the plain-
tiff and the subsequent pregnancy and related complications 
which developed. The plaintiff also asserts product liability 
claims against Searle Pharmaceuticals, Inc. ("4Searle"), based 
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upon the contention that the Cu-7 is "defective and unreasonably 
dangerous". 
B. COURSE OF PROCEEDINGS 
After legal action had been initiated, discovery was 
undertaken including the depositions of the plaintiffs and Dr. 
Porter. Thereafter, the Court held a Scheduling Conference at 
which time dates were set for the designation of expert witness-
es by plaintiff, the designation of expert witnesses by defen-
dants, the completion of discovery, and trial. The plaintiff 
failed to designate the expert witnesses by the established 
date; thereafter, Searle designated its expert witnesses and 
filed a Motion for Summary Judgment supported by the affidavit 
of one of its expert witnesses. Belatedly, plaintiff filed an 
affidavit from one of her expert witnesses; however, the affi-
davit failed to indicate that the expert witness had reviewed 
the medical records relating to the case and failed to address 
the issue of whether the Cu-7 had caused any injury to plain-
tiff. 
C. DISPOSITION AT TRIAL COURT 
Notwithstanding the fact that the affidavit from 
plaintiff's expert witness was untimely filed, the Court consid-
ered the same and ruled that the plaintiff had "shown no expert 
evidence or testimony to demonstrate a causal link between any 
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negligence on the part of defendant Searle and plaintiff's in-
juries" and that "summary judgment is appropriate". 
D. STATEMENT OF RELEVANT FACTS 
1. January 17, 1983—Dr. Porter inserted a Cu-7 into 
the uterus of the plaintiff; the Cu-7 was manufactured and dis-
tributed by Searle. (R. 1; R. 25.) 
2. The plaintiff claims that the Cu-7 perforated her 
uterus. Subsequent to the insertion of the Cu-7, plaintiff 
became pregnant, and on May 13, 1983, aborted. (R. 1.) 
3. August 8, 1985—Plaintiff initiated legal action 
against Dr. Porter and Searle and asserted claims relating to 
the Cu-7 based on strict products liability, negligence, breach 
of express and implied warranties, and for punitive damages. 
(R. 1.) 
4. May 8, 1987—The District Court ordered that 
plaintiff designate expert witnesses by July 1, 1987 and that 
defendants designate expert witnesses by August 1, 1987. 
(Scheduling Order; R. 177.) 
5. July 1, 1987 — Plaintiff failed to designate any 
expert witnesses. (R. 181; R. 137.) 
6. July 30, 1987—Searle filed its Designation of 
Expert Witnesses which included Howard G.McQuarrie, M.D. Searle 
also filed a Motion for Summary Judgment supported by the Affi-
davit of Howard G. McQuarrie, M.D. (R. 202.) 
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7. August 13, 1987—-Plaintiff filed a Motion for 
Extension of Time in Which to Respond to Defendants' Motion for 
Summary Judgment in which she sought a 30 day extension of time 
to allow her "newly-retained experts" an opportunity to "docu-
ment their opinions," (R. 244; R. 266.) 
8. August 27, 1987—The District Court made a "Rul-
ing" which granted plaintiff's Motion for Extension of Time as 
to Dr. Porter, but denied the Motion as to Searle and granted 
the Motion for Summary Judgment of Searle. However, the Summary 
Judgment In Favor Of Searle Pharmaceuticals, Inc. was not signed 
by the Court at that time. (R. 310.) 
9. September 8, 1 987 —Plaintiff filed her Designa-
tion of Expert Witness which included Charles W. March, M.D., 
and Robert E. Baier, PhD. (R. 315.) 
10. September 15, 1987 — Plaintiff filed a Request for 
Relief from Judgment pursuant to Utah Rules of Civil Procedure 
60(b), and filed therewith the Affidavit of Robert E. Baier, 
PhD. (R. 368; R. 322.) 
11. January 27, 1988—After hearing oral arguments, 
the Court ruled that the Affidavit of Robert E. Baier, PhD was 
insufficient to create a prima facie case against Searle and the 
Summary Judgment was signed and entered. (R. 454.) 
SUMMARY OF ARGUMENTS 
The plaintiff's claims against Searle involve ques-
tions and issues that are not within the general knowledge and 
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understanding of lay persons and expert testimony was, there-
fore, necessary. 
Plaintiff has failed to produce expert testimony to 
support the claim that the Cu-7 was the cause of her injury. 
Conversely, Searle produced the Affidavit of Howard G. 
McQuarrie, M.D., who expressed his opinion that the injury to 
the plaintiff was not caused as a result of any defective and 
unreasonably dangerous condition of the Cu-7 or as a result of 
any negligence or other fault on the part of Searle. 
Although plaintiff belatedly filed the Affidavit of 
Robert E. Baier, PhD, this Affidavit was insufficient to create 
a prima facie case against Searle, primarily for the reason that 
it did not address the issue of causation. 
The issue as to causation is uncontroverted in favor 
of Searle, and the Summary Judgment was appropriately granted. 
ARGUMENT 
POINT I. 
EXPERT TESTIMONY IS NECESSARY 
TO ESTABLISH PLAINTIFF'S CLAIMS 
Expert testimony is necessary where matters are at 
issue that are not within the general knowledge and understand-
ing of average citizens. 
In Nixdorf v. Hicken, 612 P.2d 3^ 8 (Utah 1980), this 
Court held: 
In a majority of medical malpractice cases 
the plaintiff must introduce expert testi-
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mony to establish this standard of care. 
Expert testimony is required because the 
nature of the profession removes the par-
ticularities of its practice from the knowl-
edge and understanding of the average citi-
zen, (Emphasis added). 
See also, Malmstrom v. Olsen, 400 P.2d 209 (Utah 1965); Kim v. 
Anderson, 610 P.2d 1270 (Utah 1980); Jennings v. Stoker, 652 
P.2d 912 (Utah 1982); and Farrow v. Health Servs. Corp., 604 
P.2d 474 (Utah 1979). 
The claims of plaintiff against Searle are medically-
related claims. The questions and issues involved include whe-
ther the Cu-7 is an effective contraceptive, whether the Cu-7 is 
defective and unreasonably dangerous, whether there was negli-
gence in the design, testing, manufacturing, and/or marketing of 
the Cu-7, whether appropriate warnings and instructions were 
given by Searle as to the Cu-7, and whether the injury suffered 
by plaintiff was caused by such claimed fault. These are all 
matters beyond the common understanding and knowledge of a lay 
person and expert testimony was necessary and anticipated by all 
parties. 
The District Court ordered the plaintiff to identify 
her experts by July 1, 1987. Plaintiff failed to do so. 
Searle timely identified its experts and filed the 
Affidavit of Howard G. McQuarrie, M.D. in support of its Motion 
for Summary Judgment. In his Affidavit, Dr. McQuarrie states, 
in relevant part, as follows: 
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3. I am familiar with the intrauterine 
copper contraceptive known as the Cu-7, 
manufactured and distributed by Searle Phar-
maceuticals, Inc. (Searle). I conducted 
clinical research relating to the Cu-7 prior 
to the approval of the same by the United 
States Food and Drug Administration in 1974, 
which approval continues to this date. I 
have reviewed numerous medical articles, 
publications, and reports relating to the 
Cu-7 as well as other intrauterine contra-
ceptive devices. I have also used the Cu-7 
in connection with my clinical practice. 
4. Based upon my education, training, ex-
perience, and upon review of the foregoing 
documents, it is my professional opinion 
that the Cu-7 is an effective contraceptive 
and is not medically defective and unreason-
ably dangerous and that Searle exercised 
appropriate judgment in connection with the 
design, testing, manufacturing, and market-
ing of the Cu-7; further, the documents 
provided with the Cu-7 by Searle gave ade-
quate and appropriate instructions, warnings 
and other information concerning the Cu-7 to 
physicians and patients who utilized the 
same . 
5. It is further my professional opinion 
that the complication which developed with 
respect to the Cu-7 which was inserted into 
the uterus of the plaintiff, Debra King, by 
the defendant, Doran V. Porter, M.D., was 
not caused as a result of any defective and 
unreasonably dangerous condition of the Cu-7 
or as a result of any negligence or other 
fault on the part of Searle;... 
(Affidavit of Howard G. McQuarrie, M.D. 1fs 3, 4, and 5; R. 205.) 
Further, the testimony of Dr. Porter was also both 
uncritical and, in fact, supportive of Searle and the Cu-7. In 
his deposition, Dr. Porter testified in relevant part, as fol-
lows : 
-7-
Q: Now, the IUD that you were placing there 
again was a Cu-7? 
A: Yes. 
Q: Why did you choose that particular type? 
A: Well, Ifve felt over the years that 
they're more affective in contraception. 
Q: Are you recommending them [the Cu-7] 
now? 
Yes. 
Are you still using them? 
Yes. 
Are you still placing them? 
Yes. 
Have the problems that Mrs. King experi-
enced caused you concern about the recommen-
dation of the Cu-7. 
A: No, not necessarily. I don't think—not 
with the function of the device. 
(Deposition of Doran V. Porter, M.D. pp. 28-32; R. 510.) 
The testimony of Dr. McQuarrie and Dr. Porter was 
unchallenged and uncontroverted. Plaintiff could not rely on 
the mere allegations of her Complaint to controvert the expert 
testimony. 
This Court, in Freed Fin. Co. v. Stoker Motor Co., 537 
P.2d 1039 (Utah 1975) held: 
A party may not rely upon allegations in the 
pleadings to counter affidavits made upon 
personal knowledge stating facts contrary to 
the allegations of the pleadings. 
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See also, Thornick v. Cook, 604 P.2d 934 (Utah 1979); and Celo-
tex Corp, v. Cartrett, 106 S.Ct. 2548 (1986) 
The District Court was correct in granting the Summary 
Judgment. 
POINT II. 
THE AFFIDAVIT OF ROBERT E. BAIER, 
PhD IS INSUFFICIENT TO ESTABLISH 
A PRIMA FACIE CASE 
A. 
THE AFFIDAVIT IS NOT COMPETENT 
Dr. Baier did not claim to have reviewed the relevant 
medical records relating to this action which would be the mini-
mum prerequisite to his being competent to offer testimony on 
the issue of causation. 
In Martin v. Mott, 744 P.2d 337 (Utah App. 1987), the 
Court affirmed summary judgment in favor of a defendant in a 
medical malpractice case due to the fact that the plaintiff 
failed to present competent expert testimony in support of her 
claim. The Court pointed out that the expert testimony proffer-
ed by the plaintiff was not competent to support the claim in 
that the expert was not familiar with the facts of the case. 
The Court stated: 
...Also, Dr. Fleming [plaintiff's expert] 
was, by his own admission, not familiar with 
any facts surrounding plaintiff's treatment. 
As stated in Edwards v. Didericksen, 597 
P.2d 1328 (Utah 1979). "The admissibility 
of [expert] evidence depends in large mea-
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sure upon the foundation laid. The exper-
tise of the witness, his degree of famili-
arity with the necessary facts, and the 
logical nexus between his opinion and the 
facts adduced must be established." (Empha-
sis in original). 
B. 
THE AFFIDAVIT WAS UNTIMELY 
This Court has previously held that summary judgment 
is appropriate due to a party's failure to comply with discovery 
deadlines and that any request for an extension of time must be 
made before the date of the discovery deadline. W.W. & W.B. 
Gardner, Inc. v. Park West Village, Inc., 568 P.2d 73^ (Utah 
1977). In this case, plaintiff failed to designate an expert 
within the allowable time set by the Court, nor did plaintiff 
request additional time to obtain an expert prior to the Court's 
deadline. 
C. 
THE AFFIDAVIT DOES NOT ADDRESS 
THE ISSUE OF CAUSATION 
Notwithstanding the deficiency in the factual basis 
supporting the Affidavit of Robert E. Baier, PhD and the untime-
ly filing of the same, as outlined above, the District Court 
considered the Affidavit which contains the following general 
statement: 
3. It is my opinion that the copper con-
tained in the Cu-7 intrauterine device has 
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an almost identical effect upon the tissues 
of the human female and this effect permits 
the device to perforate the uterus and mi-
grate to other parts of the body. 
4. In my opinion, the Cu-7 is an inherently 
dangerous device inappropriate for implanta-
tion in the female uterus. 
(Affidavit of Robert E. Baier, PhD 1[s 3 and 4; R. 370.) 
Significantly, the Affidavit is completely silent as to causa-
tion. 
A substantially identical issue was recently raised in 
Hoopiiaina v. Intermountain Health Care, 740 P.2d 270 (Utah App. 
1987). In that case, the plaintiff asserted a medical malprac-
tice claim against LDS Hospital due to the fact that she was 
given a drug which had been ordered for another patient. The 
Hospital admitted that it had been negligent in administering 
the drug to the plaintiff, but denied that the drug caused 
plaintiff any injury. The Hospital filed a Motion for Summary 
Judgment based upon this contention, which was supported by 
appropriate affidavits from experts. The Motion was granted 
because, as here, the plaintiff failed to produce any expert 
testimony to establish causation, i.e., that he had been damaged 
by the Hospital's negligence. The Court stated in relevant part 
as follows: 
In medical malpractice actions, the plain-
tiff must provide expert testimony to estab-
lish: 1) The standard of care, Marsh y. 
Pemberton, 10 Utah 2d 40, 347 P. 2d 1108, 
1110 (T959); 2) defendant's failure to 
comply with that standard, Nixdorf v. 
Hicken, 612 P.2d 348, 351 (Utah 1980); and, 
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3) that defendant caused plaintiff's injur-
ies, Huggins v. Hicken, 6 Utah 2d 233, 310 
P.2d T23i 52^ (1957). Further, issues of 
fact which are outside the knowledge and 
experience of lay persons must be establish-
ed by expert testimony. Kim v. Anderson, 
610 P.2d 1270, 1271 (Utah 1980) . 
...In the absence of an expert to testify 
for plaintiff that the quinidine harmed him, 
the court correctly concluded that the jury 
would have no evidence upon which to base a 
finding that the quinidine caused any harm 
to plaintiff.... Thus, no genuine disputes 
of material fact existed to preclude grant-
ing the motion for summary judgment. 
Further, in the recent decision of Chadwick v. 
Nielson, 94 U.A.R. 45 (Utah App. 1988), the Court held: 
The medical malpractice plaintiff must still 
ordinarily provide expert testimony...to 
establish that the doctor's negligence prox-
imately caused plaintiff's injury [citations 
omitted]. In other words, while it may be 
common knowledge that a reasonable medical 
practitioner would not leave a needle in a 
patient's body, it requires expert testimony 
to establish that the lost needle is caus-
ing, for example, plaintiff's headaches. 
(Emphasis added). 
Although plaintiff belatedly produced expert testimony 
supporting her claim that the Cu-7 is "inherently dangerous", 
thus arguably creating a question of fact as to that issue, 
plaintiff failed to produce any evidence to establish that the 
Cu-7 caused her injury. The District Court correctly ruled that 
this deficiency was fatal and that plaintiff's claim must there-
fore fail. 
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D. 
THE INVOCATION OF RES IPSA LOQUITUR 
DOES NOT RELIEVE PLAINTIFF FROM 
PROVING CAUSATION 
Plaintiff also relies for the first time on appeal on 
the doctrine of res ipsa loquitur in her claim that the Summary 
Judgment was inappropriate. However, plaintiff is in error in 
her claim that the mere invocation of the doctrine relieves a 
plaintiff of the burden of proving causation. 
In Robinson v. Intermountain Health Care, 740 P.2d 262 
(Utah App. 1987), the Court held: 
The mere invocation of the doctrine [res 
ipsa loquitur], however, does not result in 
its automatic application. In order to rely 
on res ipsa loquitur, a plaintiff must first 
establish a sufficient evidentiary founda-
tion to support application of the doctrine 
and its inference of negligence. 
...Commenting on the plaintifffs dilemma in 
making this preliminary foundational showing 
in a medical malpractice action, the Utah 
Supreme Court has noted: 
Generally, this requires the introduc-
tion of expert medical testimony to 
establish the fact that the outcome is 
more likely the result of negligence 
than some other cause. This testimony 
would be necessary to provide the 
evidentiary basis from which the jury 
could conclude the result is more 
probably than not due to the negli-
gence of the attending physician. 
In order to create a genuine factual dispute 
on this point, Robinson thus had to come 
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forward with evidence to counter Dr. Burke's 
affidavit opinion—that non-negligence 
causes of her infection were probable—with 
expert testimony to the effect that 
Robinson's infection most likely resulted 
from negligence, assuming it was possible to 
find an expert who could and would make such 
a statement.... 
See also, Talbot v. Groves Latter-Day Saints Hosp., 21 Utah 2d 
73, 440 P.2d 872 (1968), wherein this Court held: 
In examining the facts of the case before 
us, we are of the opinion that there is 
insufficient foundation on which to base the 
doctrine of res ipsa loquitur. The fact 
plaintiff's disability resulted from an 
uncommon or rare occurrence does not release 
him from the burden of establishing causa-
tion . An inference of negligence cannot be 
permitted solely upon the basis that the 
plaintiff developed a rare complication 
while undergoing medical and surgical treat-
ment. The doctrine of res ipsa loquitur has 
no application unless it can be shown from 
past experience that the occurrence causing 
the disability is more likely to result from 
negligence than some other cause.... (Em-
phasis added). 
Invoking the doctrine of res ipsa loquitur does not 
waive the requirement of producing expert testimony as to causa-
tion, and the plaintiff has produced none. 
Further, the plaintiff raises this issue for the first 
time on appeal. This Court has consistently held that an issue 
raised for the first time on appeal cannot be considered and 
should so hold in this case. See, e.g. Lane v. Messer, 731 P.2d 
488 (Utah 1986); Bundy v. Century Equip. Co., 692 P.2d 754 (Utah 
1984); and Combe v. Warren's Family Drive-ins, Inc., 680 P.2d 
733 (Utah 1984). 
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E. 
PLAINTIFF'S OTHER EXPERT IS 
NOT CRITICAL OF THE THE Cu-7 
It should also be noted that plaintifffs other expert, 
Charles W. March, M.D., whose deposition was taken after the 
District Court granted the Summary Judgment is not critical of 
the Cu-7- Dr. March testified in relevant part as follows: 
Q: I get the impression that you do not 
quarrel with the decision to use a Copper 7? 
A: No. 
Q: And you think the choice of device was 
proper? 
A: I would probably have used a plastic 
device in a woman, if I remember, who had 
three children. But, again, absolutely 
nothing wrong with the Copper 7. 
Q: And the choice of Copper 7 was within 
the standard of care? 
A: Correct. 
Q: ...As of January f83, it was your opin-
ion that the Copper 7 was a safe device, is 
that right, relatively safe device? 
A: And that there was no conclusive evi-
dence to the contrary. 
Q: And have you learned anything since then 
that would change your mind? 
A: No. 
(Charles W. March, M.D. depo., pp. 13, 14, 21 and 29). 
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The fact that plaintiff's expert, who had reviewed the 
relevant medical records, has no quarrel with Searle's position 
and the use of the Cu-7, further strengthens the conclusion that 
Summary Judgment was appropriate. 
CONCLUSION 
Plaintiff has failed to produce any evidence that the 
injury she sustained was caused by claimed "defective and unrea-
sonably dangerous" conditions of the Cu-7, and her claim against 
Searle cannot be maintained. The Summary Judgment should be 
affirmed. 
DATED this 15th day of December, 1988. 
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ADDENDUM "A" 
J. ANTHONY EYRE (#1022) 
KIPP AND CHRISTIAN, P.C. 
Attorney for Defendant 
Searle Pharmaceuticals Inc. 
City Centre I, #330 
175 East Fourth South 
Salt Lake City, Utah 84111 
Telephone: (801) 521-3773 
IN THE FOURTH JUDICIAL DISTRICT COURT OF UTAH COUNTY 
STATE OF UTAH 
DEBRA KING and CURTIS KING, : 
Plaintiffs, : AFFIDAVIT OF 
HOWARD G. McQUARRIE, M.D. 
vs. 
DORAN V. PORTER, M.D. and : 
SEARLE PHARMACEUTICALS INC. 
a foreign corporation, : Civil No. 70,361 
Defendants. : 
STATE OF UTAH ) 
) ss. 
County of Salt Lake ) 
Howard G. McQuarrie, M.D., being first duly sworn, 
deposes and says: 
1. I am a physician licensed to practice medicine 
in the State of Utah and have a speciality in the field 
of Obstetrics and Gynecology. A copy of my Curriculum 
Vitae setting forth in general my education, training, 
qualifications and experience is attached as Exhibit "A". 
2. I have reviewed the following documents re-
lating to this case: 
a. Medical records: 
Richard W. Lohner, M.D. and Kent R. 
Gammett, M.D. 
Samuel J. Hammond, M.D. 
Doran V. Porter, M.D. 
Utah Valley Hospital — 12/1/79 - 12/4/79 
Orem Community Hospital ~ 8/22/82 
Orem Community Hospital ~ 11/25/82 - 11/30/82 
Utah Valley Hospital — 4/19/83 
Orem Community Hospital — 4/21/83 
Provo Surgical Center — 5/13/83 
b. Depositions: 
Doran V. Porter, M.D. — 2/12/86 
Debra King ~ 4/09/86 
Curtis King — 4/09/86 
c. Searle Pharmaceuticals Inc. documents accom-
panying the Cu-7: 
Physician Insert — 4/08/82 (Attached as 
Exhibit "B") 
"For The Patient" Brochure — 4/12/82 (Attached 
as Exhibit "C") 
3. I am familiar with the Intrauterine Copper 
Contraceptive known as the Cu-7 manufactured and distributed 
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by Searle Pharmaceuticals Inc. (Searle). I conducted 
clinical research relating to the Cu-7 prior to the approval 
of the same by the United States Food and Drug Administration 
in 1974 which approval continues to this date. I have 
reviewed numerous medical articles, publications and reports 
relating to the Cu-7 as well as other intrauterine contracep-
tive devices. I have also used the Cu-7 in connection 
with my clinical practice. 
4. Based upon my education, training, experience 
and upon a review of the foregoing documents, it is my 
professional opinion that the Cu-7 is an effective 
contraceptive and is not medically defective and unreasonably 
dangerous, and that Searle exercised appropriate judgment 
in connection with the design, testing, manufacturing and 
marketing of the Cu-7; further, the documents provided 
with the Cu-7 by Searle gave adequate and appropriate 
instructions, warnings and other information concerning 
the Cu-7 to physicians and patients who utilized the same. 
5. It is further my professional opinion that 
the complication which developed with respect to the Cu-7 
which was inserted into the uterus of the plaintiff, Debra 
King, by the defendant Doran V. Porter, M.D. was not caused 
as a result of any defective and unreasonably dangerous 
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condition of the Cu-7 or as a result of any negligence 
or other fault on the part of Searle; perforation of the 
uterus by the Cu-7 at the time of insertion can occur in 
the absence of negligence or fault on the part of the 
treating physician or any other party. 
DATED this £Cf day of July, 1987. 
HOWARD G. McQUARRIE, M.D. 
SUBSCRIBED AND SWORN to before me this cS 7 7^ 
day of July, 1987. 
My Commission Expires: 
/••2-/^-?y 
NOTARYjPUBLIC, residing at 
L &•/_( jf'sL-t. 
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ADDENDUM "B" 
WAYNE B. WATSON, P.C. - 3405 
TERRI C. BINGHAM - 454 0 
WATSON, SEILER & OREHOSKI 
Attorneys for Plaintiff 
2696 N. University Ave., Suite 220 
Provo, UT 84604 
Telephone: (801) 375-5600 
IN THE FOURTH JUDICIAL DISTRICT COURT OF UTAH COUNTY 
STATE OF UTAH 
DEBRA KING, et al.. 
Plaintiff, 
vs. 
DORAN V. PORTER, M.D., et 
al. , 
Defendants. 
AFFIDAVIT OF ROBERT E. 
BAIER, Ph.D. 
Civil No. 70361 
(Judge Cullen Y. Christensen) 
STATE OF NEW YORK ) 
:ss. 
COUNTY OF ERIE ) 
ROBERT E. BAIER, being first duly sworn upon his oath, 
states as follows: 
1. I am the director of the Health-Care Instruments and 
Devices Institute located at the State University of New York at 
Buffalo. A biographical sketch, which outlines my qualifications 
to render the opinions which follow, is attached as Exhibit "A". 
2. I have participated in e-1 ir.ioal studies to determine 
the effect of pure metallic copper upon animal tissues. Speci-
fically, I have observed the effect of copper, implanted beneath 
the skin of New Zealand white rabbits. The copper caused tissue 
destruction of such gross magnitude that within 20 days the implant 
perforated the animal's skin and dropped to the floor of its cage. 
3. It is my opinion that the copper contained in the CU-7 
intrauterine device has an almost identical effect upon the 
tissues of the human female, and this effect permits the device 
to perforate the uterus and migrate to other parts of the body. 
4. In my opinion the CU-7 is an inherently dangerous 
device inappropriate for implantation in the female uterus. 
DATED this j ^ day of September, 1987. 
V _ > 
ROBERT E. BAIER, Ph.D. 
SUBSCRIBED and SWORN to before me this - -^ -day of Septem-
ber, 1987. 
NOTARY PUBLIC 
My Commission Expires: 
Residing at: 
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ADDENDUM "C" 
DISTRICT COURT OF UTAH COUNTY, 
STATE OF UTAH 
Case No. 70361 
RULING 
DEBRA KING, 
Plaintiff, 
vs. 
DORAN V. PORTER, M.D., et al., 
Defendants. 
This matter comes before the Court, under Rule 2.8, 
on the motion of plaintiff seeking relief from the Court's 
Ruling of August 28, 1987 granting a Summary Judgment in 
favor of defendant Searle Pharmaceutical. The Court has 
reviewed the file, considered the memoranda of counsel, 
entertained nrsuiaent; of counsel, and upon being advised 
in the premises, now makes the following: 
RULING 
1. Said motion is denied on the following bases: ^  
(a) Even though plaintiff has now designated 
her purported expert witness as heretofore ordered by the 
Court and has responded to defendant Searle!s Motion for 
Summary Judgment, such response, which has been fully considered 
by the Court, is, in the opinion of the Court, insufficient 
to forestall Summary Judgment. 
In Hoopiiaina v. IHC, 740 P.2d 270, the Utah 
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Court of Appeals held that: 
"In medical malpractice actions the plaintiff must 
provide expert testimony to establish: 1) the standard 
of care, Marsh v. Pemberton, 10 Utah 2.d 40, 347 P.2d 
1108, 1110 (1959); 2) defendant's failure to comply with 
that standard, Nixdorf v. Hicken, 612 P.2d 348, 351 (Utah 
1980); and 3) that defendant caused plaintiff's injuries. 
Huggins v. Hicken, 6 Utah 2d 233, 310 P.2d 523, 526 (1957). 
Further issues of fact which are outside the knowledge 
and experience of lay persons must be established by expert 
tesitmony. Kim v. Anderson, 610 P.2d 1270, 1271 (Utah 
1980). 
Defendant Searle in support of its Motion Summary 
Judgment submitted the Affidavit of Dr. Howard G. McQuarrie, 
M.D. as an expert who, after reviewing all of the relevant 
medical records and other documents pertaining to plaintiff's 
claims, affirmed as follows: 
"3. I am familiar with the intrauterine copper contra-
ceptive known as the CU-7, manufactured and distributed 
by Searle Pharmaceuticals, Inc. (Searle). I conducted 
clinical research relating to the CU-7 prior to the approval 
of the same by the United States Food and Drug Adminis-
tration in 1974, which approval continues to this date. 
I have reviewed numerous medical articles, publications 
and reports relating to the CU-7 as well as other intra-
uterine contraceptive devices. I have also used the CU-7 
in connection with my clinical practice. 
fl4. Based upon my education, training, experience, 
and upon review of the foregoing documents, it is my 
professional opinion that the CU-7 is an effective contra-
ceptive and is not medically defective and unreasonably 
dangerous and that Searle exercised appropriate judgment 
in connection with the design, testing, manufacturing, and 
marketing of the CU-7; further, the documents provided with 
the CU-7 by Searle gave adequate and appropriate instructions, 
warnings, and other information concerning the CU-7 to 
physicians and patients who utilized the same. 
"5. It is further my professional opinion that the 
complication which developed with respect to the CU-7 which 
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developed with respect to the CU-7 which was inserted into 
the uterus of the plaintiff, Debra King by the defendant 
Doran V. Porter, M.D., was not caused as a result of any 
defective and unreasonably dangerous condition of the CU-7 
or as a result of any negligence or other fault on the 
part of Searle; . . ." 
Plaintiff in a response to said Affidavit has 
filed an Affidavit by Robert E. Baier, Ph.D, as an expert, 
who did not purport to have examined any of the medical 
records in this case and whose experiments with respect to 
the CU-7 were conducted on rabbits, who affirmed as follows: 
"3. It is my opinion that the copper contained in the 
CU-7 intrauterine device has an almost identical effect 
upon the tissues of the human female, and this effect permits 
the device to perforate the uterus and migrate to other 
parts of the body. 
I!4. In my opinion the CU-7 is an inherently dangerous 
device inappropriate for implantation in the female uterus/1 
Even assuming for the sake of argument that the 
Baier Affidavit raises a genuine issue of fact as to plaintiff's 
claim that the CU-7 is "inherently dangerous," an assumption 
which the case of Martin v. Mott, 68 Ut. Adv. Rep. 33, 
would belie because of the unfamiliarity of Baier with the 
records in the case, such affidavit does not, nor has 
plaintiff through any other means attempted to establish 
through credible evidence that the CU-7 caused any injury 
or damage to the plaintiff. Plaintiff has thus failed to 
make out a prima facie case against defendant Searle. 
In Hoopiiaina, supra, the Court of Appeals noted 
that expert testimony was necessary to establish the fact 
that the conduct of the defendant caused plaintiff harm 
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and stated: 
"In the absence of an expert to testify for plaintiff 
that the quinidine harmed him, the court correctly concluded 
that the jury would have no evidence upon which to base 
a finding that the quinidine caused any harm to plaintiff. 
. . • Thus, no genuine disputes of material fact existed 
to preclude granting the motion for summary judgment." 
Plaintiff asserted in oral argument that in any event the 
doctrine of res ipsa loquitur is prima facie applicable so 
as to preclude summary judgment. That doctrine may in 
unusual circumstances be permitted to carry the burden of 
establishing a duty of reasonable care owed by the defendant 
to the plaintiff and a breach of that duty. It is an 
evidentiary doctrine aiding in the proof of negligence; 
it has no bearing on the issue of causation, which must be 
separately and independently established. This was so held 
in Robinson v. IHC, 62 Ut. Adv. Rep. 21. The Robinson 
Court further quoted from Anderton v. Montgomery, 607 P.2d 
828 as follows: 
"As in any negligence action, a legally-recognizable 
causal link must be established between defendant's act or 
omission and plaintifffs injury. Absent such a causal 
relationship, defendant's conduct, negligent or otherwise, 
gives rise to no liability. Res Ipsa loquitur does not 
relieve plaintiff of this obligation; rather, it permits 
him, in lieu of linking his injury to a specific act on 
defendant's part, to causally connect it with an agency or 
instrumentality, under the exclusive control of the defen-
dant, functioning in a manner which, under the circumstances, 
would produce no injury absent negligence. However, where 
the agency or instrumentality is not established to be the 
cause of plaintiff's injury, or where it is not shown to be 
under the exclusive control of the defendant, the causal 
connection is not established, and the inference of negligent 
conduct giving rise thereto is nullified." 
This Court is of the opinion that plaintiff has 
shown no expert evidence or testimony to demonstrate a causal 
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link between any negligence on the part of defendant Searle 
and plaintiff's injuries. Thus summary judgment is appro-
priate. 
For the reasons hereinabove stated Summary Judgment 
against plaintiff and in favor of defendant Searle is 
confirmed and granted. The proposed judgment heretofore 
submitted by counsel for said defendant has been signed 
this date. 
The proposed Order denying plaintiff's motion for 
relief from judgment or Order heretofore submitted by counsel 
for said defendant has likewise been signed this date. 
The proposed Order denying plaintiff's Motion for 
Extension of Time in which to Answer Defendant's Motion for 
Summary Judgment as to Searle Pharmaceutical heretofore 
submitted by counsel for said defendant is refused and is 
returned to counsel herewith unsigned. 
Dated this y7~ day of January 1988. 
BY THE COURT: 
IN THE FOURTH JUDICIAL DISTRICT COURT 
UTAH COUNTY, STATE OF UTAH 
DEBRA KING, et al., 
Plaintiffs, CASE NUMBER: 70,361 
vs. DATE: JANUARY 27, 1988 
DORAN V. PORTER, et al., CULLEN Y. CHRISTENSEN, JUDGE 
Defendants. 
PROOF OF MAILING 
I, Sandra Starley, being first duly sworn according to 
law, upon oath, depose and say: that I am a citizen of the 
United States of America, over the age of twenty-one years; that 
on the 27th day of January, 1986, I deposited in the United 
States Post Office at Provo, Utah, enclosed in sealed envelopes 
with first-class postage fully prepaid theron, true copies of 
said ruling to the following to-wit: 
Wayne B. Watson 
Terri C. Bingham 
WATSON, SEILER & OREHOSKI 
2696 N. University Ave, Suite 220 
Provo, Utah 84604 
J. Anthony Eyre 
KIPP & CHRISTIAN, P.C. 
175 East 400 South, Suite 330 
Salt Lake City, Utah 84111 
David W. Slagle 
SNOW, CHRISTENSEN & MARTINEAU 
P.O. Box 45000 
Salt Lake City, Utah 84145 
Dated this 27th day of January, 1988 
i > J-hf 
ADDENDUM "D" 
J. ANTHONY EYRE (#1022) 
KIPP AND CHRISTIAN, P.C. 
Attorney for Defendant 
Searle Pharmaceuticals Inc. 
City Centre I, #330 
175 East Fourth South 
Salt Lake City, Utah 84111 
Telephone: (801) 521-3773 
IN THE FOURTH JUDICIAL DISTRICT COURT OF UTAH COUNTY 
STATE OF UTAH 
DEBRA KING and CURTIS KING, : 
Plaintiffs, : SUMMARY JUDGMENT IN 
FAVOR OF 
vs. : SEARLE PHARMACEUTICALS INC. 
DORAN V. PORTER, M.D. and 
SEARLE PHARMACEUTICALS INC., 
a foreign corporation, : Civil No. 70,361 
Defendants. : 
The Motion For Summary Judgment of Searle 
Pharmaceuticals Inc. having been considered by the Court, 
including the Memorandum of Authorities in support of the 
Motion; the Court being fully advised in the premises and 
having heretofore entered in writing its Ruling on the 
Motion, now enters the following Order: 
1. The Motion For Summary Judgment of Searle 
Pharmaceuticals Inc. is granted. 
an d Q /7i&*, J* <J Covtp la /# b 
2o The Complaint/7 of the plaintiff Debra King 
against the defendant Searle Pharmaceuticals Inc. is 
dismissed with prejudice. 
DATED this 2 / day of §04=&£5^, 19SS& 
BY THE COURT: 
(Sullen Y.^aristensen 
District Court Judge 
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CERTIFICATE OF MAILING 
MAILED, postage prepaid, this r^K day of 
August, 1987, a true and correct copy of the foregoing 
Summary Judgment In Favor Of Searle Pharmaceuticals, to 
the following: 
Wayne B. Watson 
Terri C. Bingham 
WATSON, SEILER & OREHOSKI 
Attorneys for Plaintiffs 
2696 North University Avenue 
Suite 220 
Provo, Utah 84604 
David W. Slagle 
SNOW, CHRISTENSEN & MARTINEAU 
Attorneys for Defendant Porter 
P. 0. Box 45000 
Salt Lake City, Utah 84145 
)Jkdk\ Tgpftfa 
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